Rock Hill, North Carolina Clinical Trials

A listing of Rock Hill, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
featured
COMMANDS - Myelodysplastic Syndromes (MDS) - ACE536-MDS-002 - US  

The study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements.   This is an interventional active-controlled, open-label, randomized Phase 3 study to compare the efficacy and safety of luspatercept …

erythropoietin
cancer
epoetin alfa
vasectomy
Carolina Blood and Cancer Care
 (3.3 away)
  • 5159 views
  • 20 Jul, 2021
  • +13 other locations
Open-label Trial in Parkinson's Disease (PD)

The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease .

carbidopa
bradykinesia
levodopa
amantadine
Metrolina Neurological Associates and Diagnostic Center
 (5.0 away) Contact site
  • 0 views
  • 31 Jul, 2021
  • +3 other locations
A Study to Assess the Efficacy Safety and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

USA036
 (5.0 away) Contact site
  • 3 views
  • 01 Aug, 2021
  • +258 other locations
Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 2b adaptive dose-finding study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Clinical Research of Rock Hill
 (3.3 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • +132 other locations
An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

The rationale for the interventional, open-label, single-arm design of JZP258-401 is to evaluate the clinical experience in participants with narcolepsy transitioning treatment from Xyrem to XYWAV.

stimulant
xyrem
Clinical Research of Rock Hill
 (3.3 away) Contact site
  • 0 views
  • 16 Jul, 2021
  • +18 other locations
Study to Assess the Efficacy Safety and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Primary Objective: Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former smokers with moderate-to-severe COPD Evaluate the efficacy of itepekimab compared …

Investigational Site Number 8400008
 (5.0 away) Contact site
  • 0 views
  • 24 May, 2021
  • +51 other locations
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

This study will assess whether switching participants who have benefitted from mepolizumab or benralizumab to GSK3511294 (Depemokimab) is non-inferior to maintaining current treatment on the annualized rate of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all participants will continue their non-biologic Baseline …

GSK Investigational Site
 (3.3 away) Contact site
  • 1 views
  • 10 Jul, 2021
  • +47 other locations
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care.

Research Site
 (33.9 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +227 other locations
A Dose Finding Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19

The purpose of this study is to establish the antiviral efficacy of ensovibep against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans, identify the optimal dose, and demonstrate its clinical value for treating COVID-19 in adult ambulatory patients

Clinical Research of Rock Hill
 (3.3 away) Contact site
  • 0 views
  • 16 Jul, 2021
  • +44 other locations
Efficacy and Safety of TD-1473 in Crohn's Disease

A Phase 2 study to evaluate the efficacy, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease with up to 48 weeks of treatment.

tumor necrosis factor
azathioprine
corticosteroids
crohn's disease
immunomodulators
Theravance Biopharma Investigational Site
 (3.3 away) Contact site
  • 317 views
  • 28 Jan, 2021
  • +208 other locations